DexFerrum (iron dextran) 50 mg/mL injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- August 2009
Warning: Risk for anaphylactic-type reactions
- Anaphylactic-type reactions, including fatalities, have followed the parenteral administration of iron dextran injection...
- Anaphylaxis and other hypersensitivity reactions have been reported after uneventful test doses as well as therapeutic doses of iron dextran injection. Therefore, administer a test dose prior to the first administration of Dexferrum.